Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Research

'If I Wanted to Have More Opportunities and Go to a Better School, I Just Had to Get Used to It’

The experiences of 32 male Aboriginal students from regional and remote towns and communities while they attended a metropolitan boarding school...

News & Events

Ads clinic update

The Perth Children’s Hospital (PCH) Adolescent Diabetes Service (ADS) clinics have had several updates thanks to your feedback, including the introduction of “Welcome to Ads group sessions” for teenagers.

News & Events

Research finds pumps deliver better long-term blood glucose control

New research from the Children’s Diabetes Centre at The Kids Research Institute Australia has found children who use an insulin pump to manage their type 1 diabetes have better long-term blood glucose control than those on insulin injections.

Theme Leads

Read about the Research Focus Area Leads at the Children's Diabetes Centre.

News & Events

Self-efficacy groups 2020

Perth Children’s Hospital’s Diabetes Service has released the dates for its self-efficacy groups for 2020.

News & Events

Diabete$ Re$earch in Au$tralia

It may surprise you to know that the Australian government has invested almost $300 million dollars since 2000 towards research and clinical trials for diabetes

Research

A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)

Pneumococcal disease (PD) remains a major health concern globally. In children, pneumococcal conjugate vaccines (PCVs) provide protection against PD from most vaccine serotypes, but non-vaccine serotypes contribute to residual disease. V114 is a 15-valent PCV containing all 13 serotypes in Prevnar 13™ and public health important serotypes 22F and 33F. This phase 3 study evaluated safety and immunogenicity of mixed PCV13/V114 regimens using a 3 + 1 dosing schedule when changing from PCV13 to V114 at doses 2, 3, or 4. 

Research

Ambient Air Pollution, Extreme Temperatures and Birth Outcomes: A Protocol for an Umbrella Review, Systematic Review and Meta-Analysis

Prenatal exposure to ambient air pollution and extreme temperatures are among the major risk factors of adverse birth outcomes and with potential long-term effects during the life course. Although low- and middle-income countries (LMICs) are most vulnerable, there is limited synthesis of evidence in such settings. This document describes a protocol for both an umbrella review (Systematic Review 1) and a focused systematic review and meta-analysis of studies from LMICs (Systematic Review 2).

News & Events

The PERSIST Study

The Persist Study Community Workshop. Help us to understand how to engage other youth who live with T1D!